{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:41:48Z","timestamp":1791013308980,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,2,25]],"date-time":"2012-02-25T00:00:00Z","timestamp":1330128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11064-012-0718-0","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T05:25:54Z","timestamp":1330061154000},"page":"1335-1343","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic Effects of Stem Cells and Substrate Reduction in Juvenile Sandhoff Mice"],"prefix":"10.1007","volume":"37","author":[{"given":"J. R.","family":"Arthur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Y.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. N.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,25]]},"reference":[{"key":"718_CR1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2990.2002.00422.x","volume":"28","author":"M Jeyakumar","year":"2002","unstructured":"Jeyakumar M, Butters TD, Dwek RA et al (2002) Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis. Neuropathol Appl Neurobiol 28:343\u2013357","journal-title":"Neuropathol Appl Neurobiol"},{"key":"718_CR2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/awg089","volume":"126","author":"M Jeyakumar","year":"2003","unstructured":"Jeyakumar M, Thomas R, Elliot-Smith E et al (2003) Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126:974\u2013987","journal-title":"Brain"},{"key":"718_CR3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2008.06.024","volume":"203","author":"S Kyrkanides","year":"2008","unstructured":"Kyrkanides S, Miller AW, Miller JN et al (2008) Peripheral blood mononuclear cell infiltration and neuroinflammation in the HexB\u2212\/\u2212 mouse model of neurodegeneration. J Neuroimmunol 203:50\u201357","journal-title":"J Neuroimmunol"},{"key":"718_CR4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.neuint.2007.12.001","volume":"52","author":"RC Baek","year":"2008","unstructured":"Baek RC, Kasperzyk JL, Platt FM et al (2008) N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice. Neurochem Int 52:1125\u20131133","journal-title":"Neurochem Int"},{"key":"718_CR5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","volume":"11","author":"K Sango","year":"1995","unstructured":"Sango K, Yamanaka S, Hoffmann A et al (1995) Mouse models of tay-sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet 11:170\u2013176","journal-title":"Nat Genet"},{"key":"718_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/5.1.1","volume":"5","author":"D Phaneuf","year":"1996","unstructured":"Phaneuf D, Wakamatsu N, Huang JQ et al (1996) Dramatically different phenotypes in mouse models of human tay-sachs and Sandhoff diseases. Hum Mol Genet 5:1\u201314","journal-title":"Hum Mol Genet"},{"key":"718_CR7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.276.5311.428","volume":"276","author":"FM Platt","year":"1997","unstructured":"Platt FM, Neises GR, Reinkensmeier G et al (1997) Prevention of lysosomal storage in tay-sachs mice treated with N-butyldeoxynojirimycin. Science 276:428\u2013431","journal-title":"Science"},{"key":"718_CR8","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","volume":"96","author":"M Jeyakumar","year":"1999","unstructured":"Jeyakumar M, Butters TD, Cortina-Borja M et al (1999) Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proc Natl Acad Sci USA 96:6388\u20136393","journal-title":"Proc Natl Acad Sci USA"},{"key":"718_CR9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1054\/bjoc.2000.1713","volume":"84","author":"MK Ranes","year":"2001","unstructured":"Ranes MK, El-Abbadi M, Manfredi MG et al (2001) N-butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br J Cancer 84:1107\u20131114","journal-title":"Br J Cancer"},{"key":"718_CR10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1098\/rstb.2003.1279","volume":"358","author":"FM Platt","year":"2003","unstructured":"Platt FM, Jeyakumar M, Andersson U et al (2003) Substrate reduction therapy in mouse models of the glycosphingolipidoses. Philos Trans R Soc Lond B Biol Sci 358:947\u2013954","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"718_CR11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.nbd.2004.04.012","volume":"16","author":"U Andersson","year":"2004","unstructured":"Andersson U, Smith D, Jeyakumar M et al (2004) Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease. Neurobiol Dis 16:506\u2013515","journal-title":"Neurobiol Dis"},{"key":"718_CR12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1471-4159.2004.02381.x","volume":"89","author":"JL Kasperzyk","year":"2004","unstructured":"Kasperzyk JL, El-Abbadi MM, Hauser EC et al (2004) N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis. J Neurochem 89:645\u2013653","journal-title":"J Neurochem"},{"key":"718_CR13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1194\/jlr.M400411-JLR200","volume":"46","author":"JL Kasperzyk","year":"2005","unstructured":"Kasperzyk JL, d\u2019Azzo A, Platt FM et al (2005) Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice. J Lipid Res 46:744\u2013751","journal-title":"J Lipid Res"},{"key":"718_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/0-387-25515-X_21","volume":"564","author":"FM Platt","year":"2005","unstructured":"Platt FM, Jeyakumar M, Andersson U et al (2005) New developments in treating glycosphingolipid storage diseases. Adv Exp Med Biol 564:117\u2013126","journal-title":"Adv Exp Med Biol"},{"key":"718_CR15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jnr.20798","volume":"83","author":"CA Denny","year":"2006","unstructured":"Denny CA, Kasperzyk JL, Gorham KN et al (2006) Influence of caloric restriction on motor behavior, longevity, and brain lipid composition in Sandhoff disease mice. J Neurosci Res 83:1028\u20131038","journal-title":"J Neurosci Res"},{"key":"718_CR16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ymgme.2008.02.005","volume":"94","author":"E Elliot-Smith","year":"2008","unstructured":"Elliot-Smith E, Speak AO, Lloyd-Evans E et al (2008) Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis. Mol Genet Metab 94:204\u2013211","journal-title":"Mol Genet Metab"},{"key":"718_CR17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","volume":"97","author":"FM Platt","year":"2008","unstructured":"Platt FM, Jeyakumar M (2008) Substrate reduction therapy. Acta Paediatr Suppl 97:88\u201393","journal-title":"Acta Paediatr Suppl"},{"key":"718_CR18","volume-title":"Substrate deprivation therapy in juvenile Sandhoff disease","author":"SB Wortmann","year":"2009","unstructured":"Wortmann SB, Lefeber DJ, Dekomien G et al (2009) Substrate deprivation therapy in juvenile Sandhoff disease. J Inherit Metab, Dis"},{"key":"718_CR19","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1471-4159.2010.06733.x","volume":"113","author":"CA Denny","year":"2010","unstructured":"Denny CA, Heinecke KA, Kim YP et al (2010) Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice. J Neurochem 113:1525\u20131535","journal-title":"J Neurochem"},{"key":"718_CR20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0006-2952(99)00384-6","volume":"59","author":"U Andersson","year":"2000","unstructured":"Andersson U, Butters TD, Dwek RA et al (2000) N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo. Biochem Pharmacol 59:821\u2013829","journal-title":"Biochem Pharmacol"},{"key":"718_CR21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0962-8924(98)01249-5","volume":"8","author":"S Ichikawa","year":"1998","unstructured":"Ichikawa S, Hirabayashi Y (1998) Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol 8:198\u2013202","journal-title":"Trends Cell Biol"},{"key":"718_CR22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1010335505357","volume":"24","author":"FM Platt","year":"2001","unstructured":"Platt FM, Jeyakumar M, Andersson U et al (2001) Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy. J Inherit Metab Dis 24:275\u2013290","journal-title":"J Inherit Metab Dis"},{"key":"718_CR23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","volume":"26","author":"TM Cox","year":"2003","unstructured":"Cox TM, Aerts JM, Andria G et al (2003) The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) gaucher disease: a position statement. J Inherit Metab Dis 26:513\u2013526","journal-title":"J Inherit Metab Dis"},{"key":"718_CR24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ana.20242","volume":"56","author":"M Jeyakumar","year":"2004","unstructured":"Jeyakumar M, Smith DA, Williams IM et al (2004) NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin. Ann Neurol 56:642\u2013649","journal-title":"Ann Neurol"},{"key":"718_CR25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/blood.V97.1.327","volume":"97","author":"M Jeyakumar","year":"2001","unstructured":"Jeyakumar M, Norflus F, Tifft CJ et al (2001) Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood 97:327\u2013329","journal-title":"Blood"},{"key":"718_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nm1548","volume":"13","author":"JP Lee","year":"2007","unstructured":"Lee JP, Jeyakumar M, Gonzalez R et al (2007) Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med 13:439\u2013447","journal-title":"Nat Med"},{"key":"718_CR27","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/stem.163","volume":"27","author":"M Jeyakumar","year":"2009","unstructured":"Jeyakumar M, Lee JP, Sibson NR et al (2009) Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease. Stem Cells 27:2362\u20132370","journal-title":"Stem Cells"},{"key":"718_CR28","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1073\/pnas.93.20.10662","volume":"93","author":"K Takamiya","year":"1996","unstructured":"Takamiya K, Yamamoto A, Furukawa K et al (1996) Mice with disrupted GM2\/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci USA 93:10662\u201310667","journal-title":"Proc Natl Acad Sci USA"},{"key":"718_CR29","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","volume":"96","author":"KA Sheikh","year":"1999","unstructured":"Sheikh KA, Sun J, Liu Y et al (1999) Mice lacking complex gangliosides develop wallerian degeneration and myelination defects. Proc Natl Acad Sci USA 96:7532\u20137537","journal-title":"Proc Natl Acad Sci USA"},{"key":"718_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exnr.2000.7504","volume":"166","author":"S Chiavegatto","year":"2000","unstructured":"Chiavegatto S, Sun J, Nelson RJ et al (2000) A functional role for complex gangliosides: motor deficits in GM2\/GD2 synthase knockout mice. Exp Neurol 166:227\u2013234","journal-title":"Exp Neurol"},{"key":"718_CR31","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1073\/pnas.0407785102","volume":"102","author":"T Yamashita","year":"2005","unstructured":"Yamashita T, Wu YP, Sandhoff R et al (2005) Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci USA 102:2725\u20132730","journal-title":"Proc Natl Acad Sci USA"},{"key":"718_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1471-4159.1975.tb06957.x","volume":"25","author":"RK Yu","year":"1975","unstructured":"Yu RK, Yen SI (1975) Gangliosides in developing mouse brain myelin. J Neurochem 25:229\u2013232","journal-title":"J Neurochem"},{"key":"718_CR33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1471-4159.1983.tb04767.x","volume":"41","author":"TN Seyfried","year":"1983","unstructured":"Seyfried TN, Miyazawa N, Yu RK (1983) Cellular localization of gangliosides in the developing mouse cerebellum: analysis using the weaver mutant. J Neurochem 41:491\u2013505","journal-title":"J Neurochem"},{"key":"718_CR34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0012-1606(87)90451-9","volume":"123","author":"TN Seyfried","year":"1987","unstructured":"Seyfried TN (1987) Ganglioside abnormalities associated with failed neural differentiation in a T-locus mutant mouse embryo. Dev Biol 123:286\u2013291","journal-title":"Dev Biol"},{"key":"718_CR35","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/j.1471-4159.1988.tb02484.x","volume":"50","author":"RK Yu","year":"1988","unstructured":"Yu RK, Macala LJ, Taki T et al (1988) Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J Neurochem 50:1825\u20131829","journal-title":"J Neurochem"},{"key":"718_CR36","unstructured":"Arthur JR, Lee JP, Snyder EY et al (2010) Therapeutic effects of stem cells and substrate reduction in Sandhoff mice. In: American society for neurochemistry 41st annual meeting, p 27, Abstract PTW06-12"},{"key":"718_CR37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/000456327901600192","volume":"16","author":"H Galjaard","year":"1979","unstructured":"Galjaard H (1979) Early diagnosis and prevention of genetic disease. Ann Clin Biochem 16:343\u2013353","journal-title":"Ann Clin Biochem"},{"key":"718_CR38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/B:BIGI.0000034429.55418.71","volume":"42","author":"EC Hauser","year":"2004","unstructured":"Hauser EC, Kasperzyk JL, d\u2019Azzo A et al (2004) Inheritance of lysosomal acid beta-galactosidase activity and gangliosides in crosses of DBA\/2J and knockout mice. Biochem Genet 42:241\u2013257","journal-title":"Biochem Genet"},{"key":"718_CR39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.expneurol.2005.04.018","volume":"194","author":"MA Parker","year":"2005","unstructured":"Parker MA, Anderson JK, Corliss DA et al (2005) Expression profile of an operationally-defined neural stem cell clone. Exp Neurol 194:320\u2013332","journal-title":"Exp Neurol"},{"key":"718_CR40","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0022-2275(20)37906-2","volume":"24","author":"LJ Macala","year":"1983","unstructured":"Macala LJ, Yu RK, Ando S (1983) Analysis of brain lipids by high performance thin-layer chromatography and densitometry. J Lipid Res 24:1243\u20131250","journal-title":"J Lipid Res"},{"key":"718_CR41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497\u2013509","journal-title":"J Biol Chem"},{"key":"718_CR42","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0022-2275(20)41284-2","volume":"19","author":"TN Seyfried","year":"1978","unstructured":"Seyfried TN, Ando S, Yu RK (1978) Isolation and characterization of human liver hematoside. J Lipid Res 19:538\u2013543","journal-title":"J Lipid Res"},{"key":"718_CR43","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0006-3002(57)90254-8","volume":"24","author":"L Svennerholm","year":"1957","unstructured":"Svennerholm L (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 24:604\u2013611","journal-title":"Biochim Biophys Acta"},{"key":"718_CR44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0003-2697(78)90373-1","volume":"89","author":"S Ando","year":"1978","unstructured":"Ando S, Chang NC, Yu RK (1978) High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species. Anal Biochem 89:437\u2013450","journal-title":"Anal Biochem"},{"key":"718_CR45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0092-8674(92)90204-P","volume":"68","author":"EY Snyder","year":"1992","unstructured":"Snyder EY, Deitcher DL, Walsh C et al (1992) Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68:33\u201351","journal-title":"Cell"},{"key":"718_CR46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/374367a0","volume":"374","author":"EY Snyder","year":"1995","unstructured":"Snyder EY, Taylor RM, Wolfe JH (1995) Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374:367\u2013370","journal-title":"Nature"},{"key":"718_CR47","first-page":"121","volume":"72","author":"EY Snyder","year":"1997","unstructured":"Snyder EY, Park KI, Flax JD et al (1997) Potential of neural \u201cstem-like\u201d cells for gene therapy and repair of the degenerating central nervous system. Adv Neurol 72:121\u2013132","journal-title":"Adv Neurol"},{"key":"718_CR48","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1073\/pnas.96.12.7029","volume":"96","author":"BD Yandava","year":"1999","unstructured":"Yandava BD, Billinghurst LL, Snyder EY (1999) \u201cGlobal\u201d cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA 96:7029\u20137034","journal-title":"Proc Natl Acad Sci USA"},{"key":"718_CR49","doi-asserted-by":"crossref","first-page":"12846","DOI":"10.1073\/pnas.97.23.12846","volume":"97","author":"KS Aboody","year":"2000","unstructured":"Aboody KS, Brown A, Rainov NG et al (2000) Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 97:12846\u201312851","journal-title":"Proc Natl Acad Sci USA"},{"key":"718_CR50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrn1829","volume":"7","author":"FJ Muller","year":"2006","unstructured":"Muller FJ, Snyder EY, Loring JF (2006) Gene therapy: can neural stem cells deliver? Nat Rev Neurosci 7:75\u201384","journal-title":"Nat Rev Neurosci"},{"key":"718_CR51","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.3171\/FOC\/2008\/24\/3-4\/E21","volume":"24","author":"DJ Guillaume","year":"2008","unstructured":"Guillaume DJ, Huhn SL, Selden NR et al (2008) Cellular therapy for childhood neurodegenerative disease. Part I: rationale and preclinical studies. Neurosurg Focus 24:E22","journal-title":"Neurosurg Focus"},{"key":"718_CR52","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.3171\/FOC\/2008\/24\/3-4\/E22","volume":"24","author":"NR Selden","year":"2008","unstructured":"Selden NR, Guillaume DJ, Steiner RD et al (2008) Cellular therapy for childhood neurodegenerative disease. Part II: clinical trial design and implementation. Neurosurg Focus 24:E23","journal-title":"Neurosurg Focus"},{"key":"718_CR53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1172\/JCI40543","volume":"120","author":"O Lindvall","year":"2010","unstructured":"Lindvall O, Kokaia Z (2010) Stem cells in human neurodegenerative disorders\u2014time for clinical translation? J Clin Invest 120:29\u201340","journal-title":"J Clin Invest"},{"key":"718_CR54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.trsl.2010.07.002","volume":"156","author":"SC Schwarz","year":"2010","unstructured":"Schwarz SC, Schwarz J (2010) Translation of stem cell therapy for neurological diseases. Transl Res 156:155\u2013160","journal-title":"Transl Res"},{"key":"718_CR55","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2174\/138920111795542633","volume":"12","author":"R Kohan","year":"2011","unstructured":"Kohan R, Cismondi IA, Oller-Ramirez AM et al (2011) Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses. Curr Pharm Biotechnol 12:867\u2013883","journal-title":"Curr Pharm Biotechnol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-012-0718-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-012-0718-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-012-0718-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T09:28:32Z","timestamp":1713605312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-012-0718-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,25]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1007\/s11064-012-0718-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,25]]}}}